Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hospira recalls devices on heels of FDA warning letter

This article was originally published in The Silver Sheet

Executive Summary

Drug-delivery device maker Hospira initiated a nationwide recall Aug. 14 of more than 30 types of devices with defective power cords that may crack and fail, potentially resulting in electrical shock, therapy delays, device failure and fires. The devices include the Acclaim Encore infusion pump, Omniflow and GemStar medication management system components, Q2 and QVue cardiac monitoring systems, and items in the LifeCare and Plum infusion pump lines. The recall came two days after FDA sent a warning letter to Hospira citing quality system regulation violations related to the faulty cords (See "1Warning Letters."
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT036391

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel